LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
19 Diciembre 2007 - 2:07PM
PR Newswire (US)
BRANCHBURG, N.J., Dec. 19 /PRNewswire-FirstCall/ -- LifeCell
Corporation (NASDAQ:LIFC), today announced plans to release
preliminary fourth quarter 2007 revenues and 2008 financial
guidance on Monday, January 7, 2008 at 8:00 a.m. Eastern. Paul
Thomas, President and Chief Executive Officer, will host a
conference call at 10:00 a.m. Eastern, to discuss the Company's
fourth quarter 2007 revenues and expected financial performance for
2008. The dial-in number for the live call is (888)
211-7292/domestic or (913) 981-4902/international. A simultaneous
webcast of the call will be available via LifeCell's website at
http://www.lifecell.com/ Corporate Information - Investor
Relations. The call will be archived on the Company's website for
at least 90 days. A recording of the live-call will be available
through January 12, 2008. The dial-in number to listen to the
recording is (888) 203-1112 or (719) 457- 0820. The replay access
code is 8968654. About LifeCell LifeCell develops and markets
innovative biologically-based products in the emerging field of
regenerative medicine for use in reconstructive, orthopedic and
urogynecologic surgical procedures. LifeCell's current marketed
products include: ALLODERM(R) regenerative tissue matrix, for
plastic reconstructive, general surgical, burn and periodontal
procedures; CYMETRA(R) (Micronized AlloDerm(R)), a particulate form
of ALLODERM(R) suitable for injection; GRAFTJACKET(R) regenerative
tissue matrix, for orthopedic applications and lower extremity
wounds; ALLOCRAFT(R)DBM, for bone grafting procedures; and
REPLIFORM(R) tissue regeneration matrix for urogynecologic surgical
procedures. The Company's research and development initiatives
include programs designed to extend the use of its current marketed
regenerative tissue matrix products into new surgical applications
as well as expanding its product line in the rapidly growing
biosurgery market. LifeCell maintains a website at
http://www.lifecell.com/. DATASOURCE: LifeCell Corporation CONTACT:
Steven T. Sobieski, Chief Financial Officer, LifeCell Corporation,
+1-908-947-1106, ; or Kevin McGrath of Cameron Associates,
+1-212-245-8800, , for LifeCell Corporation Web site:
http://www.lifecell.com/
Copyright
Lifecell Corp (MM) (NASDAQ:LIFC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Lifecell Corp (MM) (NASDAQ:LIFC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Lifecell Corp (MM) (NASDAQ): 0 recent articles
Más de Lifecell (MM) Artículos de Noticias